Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Patents

Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler

PatentProstate Cancer

21.10.2024

Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler from TRUSTLIFE

ÖZET

Buluş, prostat adenokarsinom hastalığının tedavisinde etkinlik gösterdiği kanıtlananyeni bileşikler ile ilgilidir.

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models
    Scientific Documents

    Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models

  • Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026
    Recent News

    Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026

Trustlife
About Trustlife Labs Drug R&D Center Contact